Page 13 - 03 Vantaggi
P. 13
Centro Studi Active substance Therapeutic area
Product name filgrastim
Nivestim somatropin Ulcerative colitis
follitropin alfa
Omnitrope filgrastim Cancer
Ovaleap infliximab Haematopoietic stem cell
Ratiograstim transplantation
epoetin zeta Neutropenia
Remsima epoetin zeta
filgrastim Pituitary dwarfism
Retacrit filgrastim Prader-Willi syndrome
Turner syndrome
Silapo
Anovulation (IVF)
Tevagrastim
Cancer
Zarzio Haematopoietic stem cell
transplantation
Neutropenia
Ankylosing spondylitis
Crohn’s disease
Psoriatic arthritis
Psoriasis
Rheumatoid arthritis
Ulcerative colitis
Anaemia
Autologous blood transfusion
Cancer
Chronic kidney failure
Anaemia
Autologous blood transfusion
Cancer
Chronic kidney failure
Cancer
Haematopoietic stem cell
transplantation
Neutropenia
Cancer
Haematopoietic stem cell
transplantation
Neutropenia
Product name filgrastim
Nivestim somatropin Ulcerative colitis
follitropin alfa
Omnitrope filgrastim Cancer
Ovaleap infliximab Haematopoietic stem cell
Ratiograstim transplantation
epoetin zeta Neutropenia
Remsima epoetin zeta
filgrastim Pituitary dwarfism
Retacrit filgrastim Prader-Willi syndrome
Turner syndrome
Silapo
Anovulation (IVF)
Tevagrastim
Cancer
Zarzio Haematopoietic stem cell
transplantation
Neutropenia
Ankylosing spondylitis
Crohn’s disease
Psoriatic arthritis
Psoriasis
Rheumatoid arthritis
Ulcerative colitis
Anaemia
Autologous blood transfusion
Cancer
Chronic kidney failure
Anaemia
Autologous blood transfusion
Cancer
Chronic kidney failure
Cancer
Haematopoietic stem cell
transplantation
Neutropenia
Cancer
Haematopoietic stem cell
transplantation
Neutropenia